GlaxoSmithKline PLC ADR (GSK)
NYSE · Healthcare · Drug Manufacturers - General
GlaxoSmithKline PLC ADR is a Healthcare company with a market capitalization of $102.57B, a trailing P/E ratio of 16.2, and a dividend yield of 3.43%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025 · in GBP
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | July 28, 2026 | $1.36 | $1.27 | +7.1% |
| Q1 2026 | April 29, 2026 | $1.26 | $1.16 | +8.6% |
| Q4 2025 | February 4, 2026 | $0.70 | $0.62 | +12.9% |
| Q3 2025 | October 29, 2025 | $1.46 | $1.26 | +15.9% |
| Q2 2025 | July 30, 2025 | $1.24 | $1.11 | +11.7% |
| Q1 2025 | April 30, 2025 | $1.20 | $1.04 | +15.4% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 13,759,806 | — | 4.5 | +7.9% |
| June 30, 2026 | 12,755,267 | — | 3.3 | +51.9% |
| June 15, 2026 | 8,398,074 | — | 2.0 | -14.0% |
| May 29, 2026 | 9,768,845 | — | 3.2 | -28.0% |
| May 15, 2026 | 13,570,360 | — | 3.7 | +2.5% |
| April 30, 2026 | 13,234,954 | — | 2.8 | -14.3% |
| April 15, 2026 | 15,452,246 | — | 4.0 | -3.8% |
| March 31, 2026 | 16,061,751 | — | 3.6 | +29.7% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is GlaxoSmithKline PLC ADR's market cap?
As of August 13, 2026, GlaxoSmithKline PLC ADR (GSK) has a market capitalization of $102.57B.
What is GlaxoSmithKline PLC ADR's P/E ratio?
GlaxoSmithKline PLC ADR trades at a trailing price-to-earnings (P/E) ratio of 16.2. Its forward P/E is 20.7.
Does GlaxoSmithKline PLC ADR pay a dividend?
Yes — GlaxoSmithKline PLC ADR pays a dividend yielding 3.43%, an annual payout of $0.68 per share.
What sector is GSK in?
GlaxoSmithKline PLC ADR is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is GlaxoSmithKline PLC ADR's short interest?
As of the July 15, 2026 FINRA settlement, 13,759,806 GSK shares were sold short. Days to cover: 4.5. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was GlaxoSmithKline PLC ADR's revenue?
In its latest reported fiscal year (ending December 31, 2025), GlaxoSmithKline PLC ADR reported revenue of 32.67B GBP and net income of 5.72B GBP.
Ask your own questions about GSK
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.